Literature DB >> 33392659

Genetic variants in NKG2D axis and susceptibility to Epstein-Barr virus-induced nasopharyngeal carcinoma.

Nguyen Hoang Viet1,2, Nguyen Quang Trung3, Le Thanh Dong1, Ly Quoc Trung4, J Luis Espinoza5.   

Abstract

BACKGROUND: Nasopharyngeal carcinoma (NPC) is a rare epithelial carcinoma arising from the nasopharyngeal region. The pathogenesis of NPC is linked to Epstein-Barr virus (EBV) infection, although genetics and lifestyle factors appears to be also implicated. NKG2D is an immunoreceptor expressed by NK and T-cell subsets that recognizes MICA protein and other ligands on tumor cells. NKG2D interaction with MICA plays a role in the immunosurveillance to viruses and cancer.
METHODS: We investigated potential associations between functional polymorphisms in NKG2D and MICA genes with NPC susceptibility. We conducted a case-control study including 255 Vietnamese patients with EBV + non-differentiated NPC and 220 healthy controls.
RESULTS: We observed a significant association between the LNK/LNK genotype of rs1049174 (a variant associated with lower NKG2D receptor expression and reduced NK cell cytotoxicity) and increased susceptibility to NPC (adjusted OR = 1.66, 95% CI 1.07-2.59; p = 0.024). Similarly, the AA genotype of MICA rs2596542 was significantly associated with NPC (adjusted OR = 2.12; 95% CI 1.22-3.81; p = 0.009). In addition, tumor specimens of NPC patients with the AA genotype displayed a higher expression level of MICA proteins and showed higher EBV titers compared with tumor tissues from patients with the GG or GA genotypes. Higher EBV copy numbers were also observed in tumors with the A allele of MICA rs1051792 (also known as MICA-129 Met/Val) compared with those with the G allele; however, MICA rs1051792 variants were not associated with NPC susceptibility. These results suggest that genetic variants in components of the NKG2D axis may influence the individual susceptibility to EBV-induced NPC.

Entities:  

Keywords:  Epstein–Barr virus; Head and neck neoplasms; NKG2D receptor; Nasopharyngeal carcinoma; Single-nucleotide polymorphism

Mesh:

Substances:

Year:  2021        PMID: 33392659     DOI: 10.1007/s00432-020-03475-5

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  51 in total

1.  Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Hematolymphoid Tumours.

Authors:  Noah A Brown; Kojo S J Elenitoba-Johnson
Journal:  Head Neck Pathol       Date:  2017-02-28

2.  Soluble MICA and anti-MICA Antibodies as Biomarkers of Nasopharyngeal Carcinoma Disease.

Authors:  Arij Ben Chaaben; Nesrine Ouni; Hayet Douik; Fayza Ayari; Hajer Abaza; Tesnim Mamoghli; Latifa Harzallah; Cathy Fortier; Wahid Boukouaci; Rajagopal Krishnamoorthy; Dominique Charron; Sonia Gara; Fethi Guemira; Ryad Tamouza
Journal:  Immunol Invest       Date:  2019-12-09       Impact factor: 3.657

3.  Global trends in nasopharyngeal cancer mortality since 1970 and predictions for 2020: Focus on low-risk areas.

Authors:  Greta Carioli; Eva Negri; Daisuke Kawakita; Werner Garavello; Carlo La Vecchia; Matteo Malvezzi
Journal:  Int J Cancer       Date:  2017-03-13       Impact factor: 7.396

4.  Whole-exome sequencing identifies MST1R as a genetic susceptibility gene in nasopharyngeal carcinoma.

Authors:  Wei Dai; Hong Zheng; Arthur Kwok Leung Cheung; Clara Sze-man Tang; Josephine Mun Yee Ko; Bonnie Wing Yan Wong; Merrin Man Long Leong; Pak Chung Sham; Florence Cheung; Dora Lai-Wan Kwong; Roger Kai Cheong Ngan; Wai Tong Ng; Chun Chung Yau; Jianji Pan; Xun Peng; Stewart Tung; Zengfeng Zhang; Mingfang Ji; Alan Kwok-Shing Chiang; Anne Wing-Mui Lee; Victor Ho-Fun Lee; Ka-On Lam; Kwok Hung Au; Hoi Ching Cheng; Harry Ho-Yin Yiu; Maria Li Lung
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-07       Impact factor: 11.205

Review 5.  Genetic polymorphisms of matrix metalloproteinases and their inhibitors in potentially malignant and malignant lesions of the head and neck.

Authors:  Ajay Kumar Chaudhary; Mamta Singh; Alok C Bharti; Kamlesh Asotra; Shanthy Sundaram; Ravi Mehrotra
Journal:  J Biomed Sci       Date:  2010-02-15       Impact factor: 8.410

6.  NKG2D gene polymorphism has a significant impact on transplant outcomes after HLA-fully-matched unrelated bone marrow transplantation for standard risk hematologic malignancies.

Authors:  J Luis Espinoza; Akiyoshi Takami; Makoto Onizuka; Hiroshi Sao; Hideki Akiyama; Koichi Miyamura; Shinichiro Okamoto; Masami Inoue; Yoshinobu Kanda; Shigeki Ohtake; Takahiro Fukuda; Yasuo Morishima; Yoshihisa Kodera; Shinji Nakao
Journal:  Haematologica       Date:  2009-10       Impact factor: 9.941

7.  Association of MICA-129 polymorphism with nasopharyngeal cancer risk in a Tunisian population.

Authors:  Hayet Douik; Arij Ben Chaaben; Neila Attia Romdhane; Habiba Ben Romdhane; Tesnim Mamoghli; Catherine Fortier; Wahid Boukouaci; Latifa Harzallah; Abderraouf Ghanem; Said Gritli; Mohamed Makni; Dominique Charron; Rajagopal Krishnamoorthy; Fethi Guemira; Ryad Tamouza
Journal:  Hum Immunol       Date:  2008-11-08       Impact factor: 2.850

Review 8.  Sensing Bacterial-Induced DNA Damaging Effects via Natural Killer Group 2 Member D Immune Receptor: From Dysbiosis to Autoimmunity and Carcinogenesis.

Authors:  J Luis Espinoza; Mika Minami
Journal:  Front Immunol       Date:  2018-01-25       Impact factor: 7.561

Review 9.  Epstein Barr Virus Associated B-Cell Lymphomas and Iatrogenic Lymphoproliferative Disorders.

Authors:  Jennifer L Crombie; Ann S LaCasce
Journal:  Front Oncol       Date:  2019-03-07       Impact factor: 6.244

10.  Single-cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal carcinoma.

Authors:  Yu-Pei Chen; Jian-Hua Yin; Wen-Fei Li; Han-Jie Li; Dong-Ping Chen; Cui-Juan Zhang; Jia-Wei Lv; Ya-Qin Wang; Xiao-Min Li; Jun-Yan Li; Pan-Pan Zhang; Ying-Qin Li; Qing-Mei He; Xiao-Jing Yang; Yuan Lei; Ling-Long Tang; Guan-Qun Zhou; Yan-Ping Mao; Chen Wei; Ke-Xu Xiong; Hong-Bo Zhang; Shi-Da Zhu; Yong Hou; Ying Sun; Michael Dean; Ido Amit; Kui Wu; Dong-Ming Kuang; Gui-Bo Li; Na Liu; Jun Ma
Journal:  Cell Res       Date:  2020-07-20       Impact factor: 46.297

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.